Subtherapeutic triazole concentrations as result of a drug-drug interaction with lumacaftor/ivacaftor.

MLA

Smeets, T. J. L., et al. “Subtherapeutic Triazole Concentrations as Result of a Drug-Drug Interaction with Lumacaftor/Ivacaftor.” Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 23, no. 3, May 2024, pp. 563–65. EBSCOhost, https://doi.org/10.1016/j.jcf.2024.01.006.

APA

Smeets, T. J. L., van der Sijs, H., Janssens, H. M., Ruijgrok, E. J., & de Winter, B. C. M. (2024). Subtherapeutic triazole concentrations as result of a drug-drug interaction with lumacaftor/ivacaftor. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, 23(3), 563–565. https://doi.org/10.1016/j.jcf.2024.01.006

Chicago

Smeets, T J L, H van der Sijs, H M Janssens, E J Ruijgrok, and B C M de Winter. 2024. “Subtherapeutic Triazole Concentrations as Result of a Drug-Drug Interaction with Lumacaftor/Ivacaftor.” Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 23 (3): 563–65. doi:10.1016/j.jcf.2024.01.006.